Esperion Therapeutics Stock Is Diving: What’s Going On?
Esperion Therapeutics Inc (NASDAQ: ESPR) shares are trading lower Monday after the company published new data on its treatment aimed at
10 Public Companies With Largest Bitcoin Holdings In 2023
As Bitcoin (CRYPTO: BTC) becomes an increasingly popular investment option, many public companies are following suit and investing in the apex cryptocurrency.
This AI Stock Has Generated 60 Times More Returns Than Microsoft, Alphabet, SPY In 2023
The artificial intelligence wave is sweeping across, with the popularity of OpenAI's ChatGPT giving this new-age technology a boost.
Tesla To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Monday
Citigroup raised the price target for The Manitowoc Company, Inc. (NYSE: MTW) from $11 to $21. Citigroup analyst Timothy Thein maintained a Neutral rating. Manitowoc shares fell 2.4% to $19.09 in pre-market trading.
Wall Street’s Most Accurate Analysts Say Hold These 2 Consumer Stocks With Over 6% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Esperion Long Term Data On Cholesterol Medication’s Ability To Cut Cardiovascular Risk Fails To Impress Investors
Esperion Therapeutics Inc (NASDAQ:ESPR) announced the full results from the CLEAR Outcomes trial, a global study of nearly 14,000 patients with…
Ciena, Apple And 3 Stocks To Watch Heading Into Monday
With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Investor Optimism Improves After Dow Snaps 4-Week Losing Streak
The CNN Money Fear and Greed index showed an improvement in overall sentiment among US investors.
US stocks moved higher on Friday as Treasury yields fell from their recent highs after investors digested comments from the Federal Reserve officials. The Dow Jones added around 1.75% last week, snapping a four-week losing streak.
Amarin Announced New REDUCE-IT Data Showing Benefit Of VASCEPA/VAZKEPA In High-Risk Patients With A Recent Acute Coronary Syndrome Event
Amarin Corporation plc (NASDAQ: AMRN) today announced a new analysis from the VASCEPA/VAZKEPA (icosapent ethyl) cardiovascular outcomes REDUCE-IT study showing the effectiveness of VASCEPA®/VAZKEPA® in patients with recent acute coronary syndrome (<12 months before randomization).
Bitcoin Liquidity Unaffected By Silvergate Fiasco, But Market Depth Remains Low
Despite the ongoing negative news around Silvergate Bank (NYSE: SI), its potential impact on Bitcoin (CRYPTO: BTC) liquidity has not been as significant as many in the market